Contact
searchSearch
HMP Global

Schizophrenia Clinical Insights

Hara Oyedeji
Clinical Insights
Considering Oral Overlap Requirements When Initiating LAIs
06/18/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, offers guidance to APPs navigating LAI initiation while considering oral overlap requirements in the treatment of schizophrenia.
In this video, Hara Oyedeji,...
06/18/2025
Psych Congress NP Institute
Hara Oyedeji
Clinical Insights
Expanding Your Schizophrenia Toolkit With Xanomeline-Trospium
06/10/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara Oyedeji, APRN, PMHNP-BC, MSEd, unpacks the use and benefits of xanomeline-trospium as a treatment option for schizophrenia.
In part 2 of this series, Hara...
06/10/2025
Psych Congress NP Institute
Hara Oyedeji
Clinical Insights
Effectively Managing Clozapine for Treatment-Resistant Schizophrenia
05/22/2025
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji, APRN, PMHNP-BC, MSEd, explores how APPs can most effectively prescribe and monitor patient progress on clozapine, the only FDA-approved treatment for treatment-resistant schizophrenia.
In this video, Hara Oyedeji,...
05/22/2025
Psych Congress NP Institute
Kristian Dambrino, MSN
Videos
When Monotherapy Doesn’t Work: Treatment Resistance in Tardive Dyskinesia
04/08/2025
Kristian Dambrino, DNP, APRN, MSN
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member Kristian Dambrino, DNP, PMHNP-BC, dives into the nuances of prescribing vesicular monoamine transporter 2 (VMAT-2) inhibitors for the long-term management of TD.
Psych Congress Faculty Member...
04/08/2025
Psych Congress Network
Andrew Penn
Clinical Insights
Building a Strong Foundation Through Neurobiology
03/30/2025
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.
In this interview from the NP...
03/30/2025
Psych Congress NP Institute
Brooke Kempf, PMHNP-BC
Clinical Insights
Improving Patient Outcomes With Early Initiation of LAIs
02/05/2025
Brooke Kempf, MSN, PMHNP-BC
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting injectables (LAIs) play in improving long-term outcomes for patients with schizophrenia? In this discussion, Brooke Kempf, PMHNP-BC, highlights the benefits of early LAI initiation, from reducing relapse rates and...
What role do long-acting...
02/05/2025
Psych Congress Network
Andrew Penn, PMHNP-BC
Clinical Insights
Best Practices for Deprescribing in Schizophrenia
12/05/2024
Andrew Penn, RN, MS, NP, CNS, APRN-BC
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn,...
12/05/2024
Psych Congress NP Institute
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Clinical Insights
Understanding Antipsychotic-Induced Movement Disorders
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress NP Institute
Jonathan Meyer
Clinical Insights
Unpacking Negative Symptoms, Medication Adverse Effects, and Emerging Schizophrenia Treatments
10/09/2024
Jonathan Meyer, MD
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Jonathan Meyer, MD, delves into...
10/09/2024
Psych Congress NP Institute
amber hoberg
Clinical Insights
Treating New Patients on Preexisting First-Generation Antipsychotic Regimens
08/20/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN, PMHNP-BC, shares insights on managing new patients to your practice who are currently on a first-generation antipsychotic treatment regimen.
Amber Hoberg, MSN, APRN,...
08/20/2024
Psych Congress NP Institute
Psych NP Institute

 

Advance Your Expertise & Gain Confidence in Your Approach at NP Institute!

Nurse Practitioners play a vital role in mental healthcare, and specialized education is key to creating the best patient outcomes. Join us at NP Institute for an in-depth, practical learning experience designed to cover everything you’ve wanted to know but have been afraid to ask.

Why Attend?

  • Expert-Led Education – Learn from world-class leaders in psychiatry
  • Deep Dive into Psychopharmacology – Master essential principles, treatments, and medications
  • Practical & Actionable – Gain confidence in your approach to manage complex cases
  • Tailored for NPs – Networking opportunities with like-minded professionals and education designed to fit your unique role in mental healthcare

Join us to expand your knowledge and enhance patient care! 

REGISTER NOW

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use